ArticleCureus2026
Difficult Airway Management After Refusal of Awake Fibreoptic Intubation in a Giant Facial Plexiform Neurofibroma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterised by café-au-lait macules, cutaneous neurofibromas, and plexiform neurofibromas, which may extensively infiltrate surrounding tissues and create significant airway challenges during anaesthesia. We report the anaesthetic management of a 33-year-old man with a giant left-sided facial plexiform neurofibroma involving the glabella, eyelid, cheek, lips, chin, and hard palate undergoing his third staged debulking surgery. Although awake fibreoptic intubation was recommended, the patient declined the procedure. A bridging airway strategy was therefore adopted using an i-gel (Intersurgical, Wokingham, UK) supraglottic airway to establish ventilation, followed by fibreoptic-guided tracheal intubation through the device. Anaesthesia and surgery were completed uneventfully with stable haemodynamics, and the patient was extubated awake before transfer to the intensive care unit. This case demonstrates that an i-gel-assisted fibreoptic intubation technique is a safe and effective alternative when awake fibreoptic intubation is refused in patients with anticipated difficult airways due to giant facial plexiform neurofibromas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.